Raia Drogasil (OTCMKTS:RADLY) Stock Price Down 6.3% – Here’s Why

Shares of Raia Drogasil S.A. (OTCMKTS:RADLY) traded down 6.3% during mid-day trading on Thursday . The stock traded as low as $3.44 and last traded at $3.44. Approximately 19,996 shares were traded during mid-day trading, a decline of 73% from the average daily volume of 73,955 shares. The stock had previously closed at $3.67.

Raia Drogasil Stock Down 6.5%

The firm has a market cap of $4.51 billion and a price-to-earnings ratio of 68.60. The business has a fifty day simple moving average of $3.70 and a 200 day simple moving average of $3.94. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.41 and a quick ratio of 0.58.

Raia Drogasil (OTCMKTS:RADLY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. Raia Drogasil had a return on equity of 18.20% and a net margin of 2.97%.The firm had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.32 billion. As a group, equities analysts forecast that Raia Drogasil S.A. will post 0.17 EPS for the current fiscal year.

About Raia Drogasil

Raia Drogasil, now operating under the brand name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of pharmacies that sells prescription and over-the-counter medicines, personal-care products, cosmetics, health and wellness items, and convenience products.

The company also provides digital shopping and delivery services through its online channels, supporting customers with medication and health-related purchases. Its operations combine physical stores with e-commerce and other healthcare-related services, serving consumers throughout Brazil.

RD Saúde was formed in 2011 through the merger of Drogasil and Droga Raia, two pharmacy chains with roots dating back to the early twentieth century.